Commission chief Ursula von der Leyen is looking to build support among member states for overarching strategy to fill the gaps that exist at a national level in prevention, diagnosis, treatment and after care of cancer patients
Nobel prize-winning scientist Harald zur Hausen steps down as chair, citing personal reasons. He is replaced by Walter Ricciardi. Bettina Ryll, founder of a patients’ group that has transformed access to novel skin cancer treatments, joins the board
